IP Library Granted Patent US 10,226,744
Granted Patent B2
US 10,226,744 · App. 14/436,216 · Granted Mar 12, 2019

Stabilization of biomimetic membranes

Inventors: Maria Ines Plasencia Gil (Odense, DK); Jakob Broberg Kristensen (Brabrand, DK); Stanley E. Mainzer (Burlingame, CA)
Assignee: DANISCO US INC
B01D71/74B01D61/002B01D69/144B01D71/06C02F1/44C07K14/245C07K14/315C07K14/37C07K14/415C02F2303/10Y02W10/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,226,744
App. No.
14/436,216
Granted
Mar 12, 2019
Kind
B2
Abstract

The present disclosure provides methods, compositions, kits and apparatuses for stabilizing membranes, membrane proteins, and/or membranes containing membrane proteins using hydrophobin.

Claims (38)

1. A method of making a stabilized biomimetic membrane comprising a membrane protein wherein the stabilized membrane is formed after adding a Class II hydrophobin to a biomimetic membrane forming solution, wherein the Class II hydrophobin is added at a concentration of 0.1 μM-50 mM.

2. The method of claim 1 , wherein the Class II hydrophobin has the general formula:

(Y1) n -B1-(X1) a -B2-B3-(X3) c -B4-(X4) d -B5-(X5) e -B6-B7-(X7) g -B8 (Y2) m

wherein:

m and n are independently 0 to 200;

B1, B2, B3, B4, B5, B6, B7 and B8 are each independently amino acids selected from Cys, Leu, Ala, Ser, Thr, Met or Gly, at least 6 of the residues B1 through B8 being Cys;

a is 6 to 12;

c is 8 to 16;

d is 2 to 20;

e is 4 to 12; and,

g is 5 to 15.

3. The method according to claim 2 , wherein all 8 of the residues B1 through B8 are Cys.

4. The method of claim 1 , wherein said membrane protein is an aquaporin.

5. The method of claim 4 , wherein said aquaporin is AQPZ.

6. The method of claim 4 , wherein the aquaporin is of plant origin.

7. The method according to claim 4 , wherein the aquaporin is selected from the group consisting of a Tonoplast Intrinsic Protein, a Plasma Membrane Intrinsic Protein, and a Nodulin-26 like Intrinsic Protein aquaporin, and mixtures and hybrids thereof.

8. The method according to claim 4 , wherein the aquaporin is an aquaglyceroporin (GLpF).

9. The method according to claim 8 , wherein said GLpF is selected from the group consisting of a GLPA channel, a GLPB1 channel, a GLPB2 channel, a GLPB3 channel, and a GLPY2 channel, and mixtures and hybrids thereof.

10. The method according to claim 1 , wherein the Class II hydrophobin has a hydrophobin core sequence of between 40 and 120 amino acids.

11. The method of claim 10 , wherein said Class II hydrophobin is selected from the group consisting of HFBII (SEQ ID NO: 2) and HFBI (SEQ ID NO: 4), or wherein said Class II hydrophobin has a hydrophobin core that has at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 99% sequence identity to the hydrophobin core of SEQ ID NO: 2.

12. The method of claim 10 , wherein said Class II hydrophobin is “HFBII” (SEQ ID NO: 2), or a protein having a hydrophobin core that has at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 99% sequence identity to the hydrophobin core of SEQ ID NO: 2.

13. The method according to claim 1 , wherein the Class II hydrophobin is a Class II hydrophobin fusion protein.

14. The method according to claim 1 , wherein the Class II hydrophobin is obtained or obtainable from a filamentous fungus.

15. The method according to claim 14 , wherein the Class II hydrophobin is obtained or obtainable from a fungus of genus selected from the group consisting of Cladosporium, Ophistoma, Cryphonectria, Trichoderma, Gibberella, Neurospora, Maganaporthe, Hypocrea, Xanthoria, Emericella, Aspergillus, Paracoccioides, Metarhizium, Pleurotus, Coprinus, Dicotyonema, Flammulina, Schizophyllum, Agaricus, Pisolithus, Tricholoma, Pholioka, Talaromyces and Agrocybe.

16. The method according to claim 1 , wherein the Class II hydrophobin is added by being generated in situ in the biomimetic membrane forming solution.

17. The method according to claim 1 , wherein the Class II hydrophobin causes at least 1.2 fold increase in stability of the biomimetic membrane compared to the stability in the absence of said Class II hydrophobin.

18. The method according to claim 1 , wherein said Class II hydrophobin provides a decrease in an equilibrium surface tension at said biomimetic membrane below 50 mN/m.

19. The method according to claim 1 , wherein said Class II hydrophobin causes the surface shear elasticity at said biomimetic membrane to increase to 0.3-0.6 N/m or higher.

20. The method according to claim 1 , wherein the Class II hydrophobin has the general formula:

(Y1) n -B1-(X1) a -B2-B3-(X3) c -B4-(X4) d -B5-(X5) e -B6-B7-(X7) g -B8-(Y2) m

wherein:

m and n are independently 0 to 10;

B1, B2, B3, B4, B5, B6, B7 and B8 are each independently amino acids selected from Cys, Leu or Ser, at least 7 of the residues B1 through B8being Cys;

a is 7 to 11;

c is 11;

d is 4 to 18;

e is 6 to 10; and

g is 7 to 10.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2018
From: MAINZER, STANLEY E.; KRISTENSEN, JAKOB BROBERG; PLASENCIA GIL, MARIA INES
To: DANISCO US INC.
Reel/Frame 044575/0626 →
Continuity (2)
Provisional Application 61716351 · Oct 19, 2012
Related Publication 20150273407A1 · Oct 1, 2015